Delivery Order SPE2DB22D2005-SPE2DB24FJGZ4
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,798.16 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of M-M-R II vaccine vials, with a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,706.51 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of M-M-R II vaccine vials and has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,347.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of M-M-R II vaccine vials and has a completion date of February 27, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA Troop Support Medical, providing a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $30,556.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of M-M-R II vaccine vials and has a period of performance through April 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to provide a comprehensive range of pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,561.90 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. This order is for the supply of M-M-R II vaccine vials, with an ultimate completion date of May 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $6,858.65, is for the delivery of M-M-R II vaccine vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,170.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,537.14 firm fixed price delivery order contract to provide M-M-R II vaccine vials. The contract has a completion date of February 28, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This award is part of Amerisourcebergen's indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide M-M-R II vaccine vials. The $1,024.76 award has a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $6,522.37 to provide M-M-R II vaccine vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJGZ4Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $6,148.56 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is for the supply of M-M-R II vaccine vials to support military treatment programs and facilities. The delivery order has a period of performance through January 29, 2024. This award is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.1k | 1/26/24 |